Feb 10, 2023 / Comment Letters

MedPAC comment on CMS’s proposed rule on policy and technical changes to the Medicare Advantage Program and Medicare Prescription Drug Benefit Program for 2024

Research Areas:

Drugs, Devices, and Tests, Medicare Spending and Financing, Private Plans

Jan 13, 2023 / RFI Responses

MedPAC’s response to a Congressional Request for Information on Dual-Eligible Beneficiaries

Research Areas:

Beneficiaries and Coverage, Quality

Jan 13, 2023 / Transcripts

January 2023 meeting transcript

Jan 13, 2023 / Presentations

Addressing high prices of drugs covered under Medicare Part B

Research Areas:

Drugs, Devices, and Tests, Medicare Spending and Financing, Quality

Jan 13, 2023 / Presentations

Medicare Part D: Status report

Research Areas:

Drugs, Devices, and Tests, Medicare Spending and Financing, Quality

Jan 12, 2023 / Presentations

Mandated report: Updates on telehealth use and beneficiary and clinician experiences

Research Areas:

Beneficiaries and Coverage, Physicians And Other Health Professionals, Quality

Jan 12, 2023 / Presentations

Congressional request: Medicare clinician and outpatient behavioral health services

Research Areas:

Medicare Spending and Financing, Physicians And Other Health Professionals, Quality

Jan 12, 2023 / Presentations

The Medicare Advantage program: Status report

Research Areas:

Medicare Spending and Financing, Private Plans

Jan 12, 2023 / Presentations

Assessing payment adequacy and updating payments: Outpatient dialysis services; hospice services; skilled nursing facility services; home health agency services; inpatient rehabilitation facility services

Research Areas:

Medicare Spending and Financing, Post-Acute Care

Jan 12, 2023 / Presentations

Assessing payment adequacy and updating payments: Physician and other health professional services; and supporting Medicare safety-net clinicians

Research Areas:

Medicare Spending and Financing, Physicians And Other Health Professionals